MPM Asset Management’s Altimmune ALT Stock Holding History

MPM Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-233	Closed	-$3K	–	8
2018 Q2	$3K	Hold	233	–	–	﹤0.01%	9
2018 Q1	$8K	Hold	233	–	–	﹤0.01%	9
2017 Q4	$14K	Hold	233	–	–	0.01%	9
2017 Q3	$16K	Hold	233	–	–	0.01%	8
2017 Q2	$22K	Buy	+233	New	+$38.7K	0.01%	9
2016 Q1	–	Sell	-21,159	Closed	-$12.1M	–	16
2015 Q4	$12.1M	Hold	21,159	–	–	2.15%	5
2015 Q3	$8.44M	Hold	21,159	–	–	1.3%	9
2015 Q2	$11.4M	Hold	21,159	–	–	1.91%	7
2015 Q1	$10.3M	Hold	21,159	–	–	2.21%	9
2014 Q4	$11.5M	Hold	21,159	–	–	2.55%	8
2014 Q3	$11.3M	Hold	21,159	–	–	3.7%	6
2014 Q2	$8.95M	Hold	21,159	–	–	3.01%	8
2014 Q1	$11.6M	Hold	21,159	–	–	4.92%	6
2013 Q4	$11.8M	Hold	21,159	–	–	3.81%	5
2013 Q3	$13.3M	Hold	21,159	–	–	3.76%	5
2013 Q2	$10.1M	Buy	+21,159	New	+$10.5M	4.47%	6

Other funds holding ALT

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

MPM Asset Management's ALT Position: Q3 2018 in Review

MPM Asset Management sold out of Altimmune (ALT) in Q3 2018, closing a stake of 233 shares — an estimated $3K sold.

MPM Asset Management first reported a position in ALT in Q2 2013 and held it in 16 quarters. The position peaked at $13.3M in Q3 2013. 16 funds tracked by Wall St. Rank hold ALT as of Q3 2018.

MPM Asset Management reported no remaining Altimmune position as of Q3 2018 after selling out during the quarter.
MPM Asset Management sold 233 Altimmune shares in Q3 2018, an estimated $3K.
MPM Asset Management first reported a position in Altimmune in Q2 2013 and held it in 16 quarters.
MPM Asset Management's Altimmune position peaked at $13.3M in Q3 2013.
16 funds tracked by Wall St. Rank held Altimmune as of Q3 2018.

Based on MPM Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.